Direct Cardiac Mechanisms of the Sodium Glucose Co-Transporter 2 Inhibitor Class
{{output}}
BackgroundSodium-glucose co-transporter 2 (SGLT2) inhibitors have demonstrated significant cardiovascular benefits in clinical trial. While their role in reducing heart failure hospitalizations and cardiovascular mortality is well established, the precise mech... ...
